US urges Pfizer to apply for under-5 COVID shots
U.S. regulators are urging drug maker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old while awaiting data on a three-dose course. (Feb. 1)
